Back

Transcriptomic analysis of C9orf72-mutated iPSC-derived microglia implicates cell-autonomous upregulation of selected NLRP3 inflammasome genes in motor neuron degeneration

Pulimood, N. S.; Thiry, L.; Tang, Y. M.; Stifani, S.

2025-02-14 neuroscience
10.1101/2025.02.13.638162 bioRxiv
Show abstract

Hexanucleotide repeat expansion (HRE) in the non-coding region of the gene C9orf72 is the most prevalent mutation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The C9orf72 HRE contributes to neuron degeneration in ALS/FTD through both cell- autonomous mechanisms and non-cell autonomous disease processes involving glial cells such as microglia. The molecular mechanisms underlying the contribution of C9orf72-HRE microglia to neuron death in ALS/FTD remain to be fully elucidated. In this study, we generated microglia from human C9orf72-HRE and isogenic iPSCs using three different microglia derivation methods. RNA sequencing analysis reveals a cell-autonomous dysregulation of extracellular matrix (ECM) genes and genes involved in pathways underlying inflammasome activation in C9orf72-HRE microglia. In agreement with elevated expression of inflammasome components, conditioned media from C9orf72-HRE microglia enhance the death of C9orf72- HRE motor neurons implicating microglia-secreted molecules in non-cell autonomous mechanisms of C9orf72 HRE pathology. These findings suggest that aberrant activation of inflammasome-mediated mechanisms in C9orf72-HRE microglia results in a pro-inflammatory phenotype that contributes to non-cell autonomous mechanisms of motor neuron degeneration in ALS/FTD. SummaryThis study describes phenotypic alterations in C9orf72-ALS/FTD microglia implicating extracellular matrix remodeling and inflammasome activation in microglia-mediated neurodegeneration in ALS/FTD.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
14.2%
2
Acta Neuropathologica
51 papers in training set
Top 0.1%
12.4%
3
Brain
154 papers in training set
Top 0.5%
10.0%
4
Neurobiology of Disease
134 papers in training set
Top 0.5%
10.0%
5
Acta Neuropathologica Communications
81 papers in training set
Top 0.1%
6.3%
50% of probability mass above
6
Annals of Neurology
57 papers in training set
Top 0.6%
3.6%
7
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.1%
2.4%
8
Scientific Reports
3102 papers in training set
Top 54%
1.9%
9
Molecular Neurobiology
50 papers in training set
Top 0.3%
1.9%
10
Journal of Neuroinflammation
50 papers in training set
Top 0.4%
1.9%
11
Nature Communications
4913 papers in training set
Top 52%
1.6%
12
Glia
74 papers in training set
Top 0.3%
1.3%
13
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.3%
14
Experimental Neurology
57 papers in training set
Top 0.9%
1.2%
15
iScience
1063 papers in training set
Top 22%
1.2%
16
Cell Reports
1338 papers in training set
Top 28%
1.2%
17
Brain Communications
147 papers in training set
Top 2%
1.2%
18
Cell Death & Disease
126 papers in training set
Top 2%
1.2%
19
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 41%
0.9%
20
Alzheimer's & Dementia
143 papers in training set
Top 2%
0.9%
21
JCI Insight
241 papers in training set
Top 6%
0.9%
22
Journal of Neurology
26 papers in training set
Top 1%
0.8%
23
The Journal of Pathology
22 papers in training set
Top 0.5%
0.7%
24
eneuro
389 papers in training set
Top 9%
0.7%
25
Human Molecular Genetics
130 papers in training set
Top 4%
0.7%
26
PLOS ONE
4510 papers in training set
Top 68%
0.7%
27
International Journal of Molecular Sciences
453 papers in training set
Top 16%
0.7%
28
Molecular Psychiatry
242 papers in training set
Top 4%
0.7%
29
Journal of Biological Chemistry
641 papers in training set
Top 5%
0.6%
30
Frontiers in Molecular Neuroscience
43 papers in training set
Top 1%
0.6%